Tissue Regenix Group (TRX) Competitors GBX 25 -0.50 (-1.96%) As of 09/12/2025 11:35 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsBuy This Stock TRX vs. NAK, EGI, IMG, EDG, MTA, NGR, RRS, NG, WPM, and IAGShould you be buying Tissue Regenix Group stock or one of its competitors? The main competitors of Tissue Regenix Group include Nakama Group plc (NAK.L) (NAK), (EGI.L) (EGI), 532753 (IMG.L) (IMG), 651814 (EDG.L) (EDG), ArcelorMittal (MTA), Nature Group (NGR), Randgold Resources (RRS), National Grid (NG), Wheaton Precious Metals (WPM), and International Consolidated Airlines Group (IAG). These companies are all part of the "precious metals" industry. Tissue Regenix Group vs. Its Competitors Nakama Group plc (NAK.L) (EGI.L) 532753 (IMG.L) 651814 (EDG.L) ArcelorMittal Nature Group Randgold Resources National Grid Wheaton Precious Metals International Consolidated Airlines Group Tissue Regenix Group (LON:TRX) and Nakama Group plc (NAK.L) (LON:NAK) are both small-cap precious metals companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, institutional ownership, dividends, analyst recommendations, risk and earnings. Does the media prefer TRX or NAK? In the previous week, Tissue Regenix Group's average media sentiment score of 0.00 equaled Nakama Group plc (NAK.L)'saverage media sentiment score. Company Overall Sentiment Tissue Regenix Group Neutral Nakama Group plc (NAK.L) Neutral Is TRX or NAK more profitable? Nakama Group plc (NAK.L) has a net margin of 0.00% compared to Tissue Regenix Group's net margin of -3.46%. Nakama Group plc (NAK.L)'s return on equity of 0.00% beat Tissue Regenix Group's return on equity.Company Net Margins Return on Equity Return on Assets Tissue Regenix Group-3.46% -2.87% 0.50% Nakama Group plc (NAK.L) N/A N/A N/A Which has higher valuation & earnings, TRX or NAK? Nakama Group plc (NAK.L) has lower revenue, but higher earnings than Tissue Regenix Group. Tissue Regenix Group is trading at a lower price-to-earnings ratio than Nakama Group plc (NAK.L), indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTissue Regenix Group£28.65M0.62-£1.11M-£0.01-2,500.00Nakama Group plc (NAK.L)£8.09M0.00N/A-£0.20N/A Do insiders and institutionals have more ownership in TRX or NAK? 3.1% of Tissue Regenix Group shares are owned by institutional investors. 6.9% of Tissue Regenix Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummaryTissue Regenix Group beats Nakama Group plc (NAK.L) on 5 of the 8 factors compared between the two stocks. Get Tissue Regenix Group News Delivered to You Automatically Sign up to receive the latest news and ratings for TRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TRX vs. The Competition Export to ExcelMetricTissue Regenix GroupBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£17.81M£236.97M£5.87B£2.58BDividend Yield4.12%3.78%5.68%5.30%P/E Ratio-2,500.0041.0874.525,410.94Price / Sales0.625,000.68516.2196,691.90Price / Cash5.7013.1937.5627.93Price / Book0.60103.7512.167.77Net Income-£1.11M-£90.99M£3.28B£5.89B7 Day Performance-16.67%2.70%0.78%6.50%1 Month Performance-10.71%21.05%4.87%55.93%1 Year Performance-59.12%530.95%60.72%147.83% Tissue Regenix Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TRXTissue Regenix GroupN/AGBX 25-2.0%N/A-59.0%£17.81M£28.65M-2,500.00120NAKNakama Group plc (NAK.L)N/AN/AN/AN/A£1.44M£8.09M-6.1353Gap DownHigh Trading VolumeEGI(EGI.L)N/AN/AN/AN/A£0.00N/A0.006Gap DownHigh Trading VolumeIMG532753 (IMG.L)N/AN/AN/AN/A£0.00N/A0.005,360High Trading VolumeEDG651814 (EDG.L)N/AN/AN/AN/A£0.00N/A0.002,610MTAArcelorMittalN/AN/AN/AN/A£0.00N/A0.009High Trading VolumeNGRNature GroupN/AN/AN/AN/A£0.00N/A0.0010Gap UpRRSRandgold ResourcesN/AN/AN/AN/A£0.00N/A0.0021,300Gap UpNGNational Grid1.5446 of 5 starsGBX 1,038+0.1%GBX 1,070+3.1%-0.4%£50.96B£25.99B17.0510News CoverageHigh Trading VolumeWPMWheaton Precious Metals1.1647 of 5 starsGBX 7,874.99+0.4%GBX 8,300+5.4%+67.7%£35.75B£1.66B4,536.2842News CoveragePositive NewsAnalyst ForecastGap UpIAGInternational Consolidated Airlines Group1.6611 of 5 starsGBX 382-0.1%GBX 403.33+5.6%+95.3%£17.67B£33.28B591.335,360 Related Companies and Tools Related Companies NAK Competitors EGI Competitors IMG Competitors EDG Competitors MTA Competitors NGR Competitors RRS Competitors NG Competitors WPM Competitors IAG Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:TRX) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tissue Regenix Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Tissue Regenix Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.